美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oncotelic Therapeutics, Inc.

0.0465

-0.0005-1.17%

成交量：3.99萬

成交額：1,921.40

市值：2,053.33萬

市盈率：- -

高：0.0500

開：0.0500

低：0.0465

收：0.0471

52周最高：0.1100

52周最低：0.0150

股本：4.42億

流通股本：2.14億

量比：0.10

換手率：0.02%

股息：- -

股息率：- -

淨資產收益率：-23.72%

總資產收益率：-1.57%

市淨率：2.27

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Oncotelic Therapeutics Inc. 修訂與Jefferson Capital Ventures的投資諮詢協議，修訂日期為2025年12月31日 - 美國證券交易委員會文件

Oncotelic與Sapu Nano發布新藥代謝數據，顯示靜脈注射Sapu003相較於口服給藥可將Everolimus的胃腸道累積減少多達67倍

Oncotelic Therapeutics - 合資公司正為2026年底在香港股票交易所的潛在首次公開募股做準備

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OTLC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OTLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OTLC\",,,,,undefined,":{"symbol":"OTLC","market":"US","secType":"STK","nameCN":"Oncotelic Therapeutics, Inc.","latestPrice":0.0465,"timestamp":1771621200000,"preClose":0.04705,"halted":0,"volume":39914,"delay":15,"changeRate":-0.011689691817215768,"floatShares":214445090,"shares":441577283,"eps":0,"marketStatus":"盤前交易","change":-0.00055,"latestTime":"02-20 16:00:00 EST 延時","open":0.05,"high":0.05,"low":0.0465,"amount":1921.4,"amplitude":0.074389,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1771857000000},"marketStatusCode":1,"adr":0,"exchange":"OTCQB","adjPreClose":0.0465,"volumeRatio":0.09569412401434804},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OTLC\",,,,,undefined,":{"symbol":"OTLC","floatShares":214445090,"roa":"-1.57%","roe":"-23.72%","lyrEps":0,"volumeRatio":0.09569412401434804,"shares":441577283,"dividePrice":0,"high":0.05,"amplitude":0.074389,"preClose":0.04705,"low":0.0465,"week52Low":0.015,"pbRate":"2.27","week52High":0.11,"institutionHeld":0,"latestPrice":0.0465,"eps":0,"divideRate":0,"volume":39914,"delay":15,"open":0.05,"prevYearClose":0.0784,"prevWeekClose":0.0465,"prevMonthClose":0.0772,"prevQuarterClose":0.0784,"fiveDayClose":0.049,"twentyDayClose":0.0765,"sixtyDayClose":0.0935},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OTLC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-19","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731992400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-14","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-12","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1712894400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-14","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OTLC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OTLC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OTLC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127910485","title":"Oncotelic Therapeutics Inc. 修訂與Jefferson Capital Ventures的投資諮詢協議，修訂日期為2025年12月31日 - 美國證券交易委員會文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1127910485","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127910485?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 06:04","pubTimestamp":1767737051,"startTime":"0","endTime":"0","summary":"Oncotelic Therapeutics Inc. 已宣布修订其与Jefferson Capital Ventures签订的投资咨询协议。此项修订于2025年12月31日完成，相关细节已通过美国证券交易委员会文件正式披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLC","BK4139"],"gpt_icon":0},{"id":"1135383485","title":"Oncotelic與Sapu Nano發布新藥代謝數據，顯示靜脈注射Sapu003相較於口服給藥可將Everolimus的胃腸道累積減少多達67倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1135383485","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135383485?lang=zh_tw&edition=fundamental","pubTime":"2025-12-03 22:01","pubTimestamp":1764770492,"startTime":"0","endTime":"0","summary":"Oncotelic与Sapu Nano发布的新药代谢数据表明，静脉注射Sapu003相较于口服给药可将Everolimus的胃肠道累积减少多达67倍。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLC","BK4139"],"gpt_icon":0},{"id":"1116354852","title":"Oncotelic Therapeutics - 合資公司正為2026年底在香港股票交易所的潛在首次公開募股做準備","url":"https://stock-news.laohu8.com/highlight/detail?id=1116354852","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116354852?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 20:57","pubTimestamp":1763643442,"startTime":"0","endTime":"0","summary":"Oncotelic Therapeutics - 合资公司正为2026年底在香港股票交易所的潜在首次公开募股做准备","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTLC","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OTLC\",params:#limit:6,delay:false,,,undefined,":[]}}